fig3

Figure 3. Characterization of sponsors and European investigator countries involved in the development of gene therapies in rare diseases. Geographical distribution (%) of (A-B) countries sponsoring gene therapy studies in rare diseases or (C-D) countries involved as investigators of those studies in gene therapy protocols in the field of rare diseases (A, C) as a map representation, or (B, D) as a pie chart representation showing associated percentages.